Language: BG BG
← Back to results
Active (not recruiting) Not applicable NCT04168372

Fructose: Substrate, Stimulus, or Both?

No applicable phase (e.g. observational)
Conditions: Insulin Resistance Insulin Sensitivity Pre Diabetes

Sponsor: Touro University, California

trial.available_in: БГ
Overview
This objective of this study is to use sensitive methodology under controlled conditions to investigate the mechanisms by which fructose consumption contributes to excess fatty acid synthesis and elevations in blood glucose levels following consumption of meals containing fructose.
Who can participate
Inclusion Criteria: * Body Mass Index 22 to 35 kg/m2 * Prediabetic (HbA1c 5.7% to 6.5%) or hyperinsulinemic (fasting insulin ≥12 µIU/mL) but non-diabetic (fasting glucose \<126mg/dL and HbA1c \< 6.5%) ; or normal control (fasting insulin \<10 µIU/mL, fasting glucose \<100 mg/dL, and HbA1c \< 5.7%) Exclusion Criteria: * Pregnancy or lactation within the past six months * Type 1 or 2 diabetes mellitus * History of liver disease or aspartate aminotransferase (AST) and alanine aminotransferase (ALT) 2x the upper limit of normal (ULN); * Fasting triglyceride or total cholesterol levels above 95th percentile for age and sex; * Hemoglobin or hematocrit below the lower limit of normal for sex; * Report of hepatitis or HIV infection; * History of cancer, use of any anti-diabetic medications or hypolipidemic agents in the past six months; * History of surgical procedure for obesity; * Self-reported change in body weight \>5% in the past six months; * History of other conditions known to affect insulin sensitivity and lipid metabolism; * Known intolerance to acetaminophen or components of the liquid test meals.
Interventions
High fructose, fructose labeled meal
OTHER
High fructose, pyruvate labeled meal
OTHER
Low fructose, fructose labeled meal
OTHER
Low fructose, pyruvate labeled meal
OTHER
Locations 1
United States (1)
Touro University California
Vallejo , California
Technical details
Status
Active (not recruiting)
Phase
Not applicable
Study type
INTERVENTIONAL
Sex
Male and female
Minimum age
20 Years
Maximum age
55 Years
Healthy volunteers
No
Start date
15.09.2019
Completion date
20.12.2026
Registry ID
NCT04168372
Source
clinicaltrials.gov
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.